3rd Circ. Panel Questions Niaspan Buyers' Class Data
By Matthew Perlman · September 6, 2022, 7:52 PM EDT
A Third Circuit panel on Tuesday raised a number of questions for Niaspan buyers about the data supporting their bid for class status in a case accusing AbbVie and Teva Pharmaceuticals...
To view the full article, register now.